In the same vein, Kerslake et al. recently demonstrated that OR51E2 is upregulated in prostate adenocarcinoma and by using the GeneMANIA software, they found that this OR interacts with a wide range of genes associated with prostate cancer, such as kallikrein 3, anoctamin 7, arrestin β2, and serine/threonine kinase 3 [28]. The gene discussed is OR51E2; the disease is prostate cancer.